Dose-adjusted EPOCH with or without rituximab for aggressive lymphoma patients: real world data | SpringerLink
Jointly sponsored by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC Workshop With the Experts: Overcoming Barriers. - ppt download
Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma | Blood Cancer Journal
Table 2 from Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy. | Semantic Scholar
Response rates of DA-EPOCH-R and R-CHOP regimen | Download Scientific Diagram
Reducing Hospitalizations: Institution of Outpatient Infusional EPOCH-Based Chemotherapy at a Safety Net Hospital | JCO Oncology Practice
DA-R-EPOCH Dose-Adjustment Paradigm
Dosing schedule of R-EPOCH regimen | Download Scientific Diagram
Making an Informed Treatment Choice for Aggressive Non-Hodgkin Lymphoma: The R-CHOP Regimen versus EPOCH-R
CONSORT diagram. ANC, absolute neutrophil count; CALGB, Cancer and... | Download Scientific Diagram
What does DA-EPOCH-R mean? - Definition of DA-EPOCH-R - DA-EPOCH-R stands for dose-adjusted etoposide, doxorubicin, and cyclophosphamide with vincristine, prednisone and rituximab without radiotherapy. By AcronymsAndSlang.com
783-DA-R-EPOCH (dose adjusted rituximab etoposide prednisolone vinCRISTine CYCLOPHOSPHamide DOXO | eviQ
Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma | NEJM
Response rates of DA-EPOCH-R and R-CHOP regimen | Download Scientific Diagram
COMPARISON OF IMMUNOCHEMOTHERAPY WITH RITUXIMAB-DOSE-ADJUSTED EPOCH.... EHA Library. Vassilakopoulos T. Jun 9 2021; 325311
Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma | NEJM
R‐CHOP versus dose‐adjusted R‐EPOCH in frontline management of primary mediastinal B‐cell lymphoma: a multi‐centre analysis - Shah - 2018 - British Journal of Haematology - Wiley Online Library
Making an Informed Treatment Choice for Aggressive Non-Hodgkin Lymphoma: The R-CHOP Regimen versus EPOCH-R
Chemotherapy and Rituximab for NHL: Results from the Dose-Adjusted EPOCH Study | Research To Practice
VisualAbstract Venetoclax with dose-adjusted EPOCH-R may be a promising combination therapy for aggressive B-cell lymphoma | 2 Minute Medicine
Low-Intensity Therapy in Adults with Burkitt's Lymphoma | NEJM
Treatment-related adverse reaction between R-CHOP and DA-EPOCH-R regimen | Download Scientific Diagram
Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707 | Haematologica
783-DA-R-EPOCH (dose adjusted rituximab etoposide prednisolone vinCRISTine CYCLOPHOSPHamide DOXO | eviQ
![PDF] Efficacy of dose-adjusted EPOCH plus rituximab/R-CHOP regimens and the prognosis analysis in patients with MYC, BCL2/BCL6 gene copy number gain lymphoma and double-hit lymphoma: results from a single institution retrospective clinical](https://d3i71xaburhd42.cloudfront.net/e653d00aceb8c630262ddb4376aa736556433fc0/4-Table2-1.png "PDF] Efficacy of dose-adjusted EPOCH plus rituximab/R-CHOP regimens and the prognosis analysis in patients with MYC, BCL2/BCL6 gene copy number gain lymphoma and double-hit lymphoma: results from a single institution retrospective clinical")
PDF] Efficacy of dose-adjusted EPOCH plus rituximab/R-CHOP regimens and the prognosis analysis in patients with MYC, BCL2/BCL6 gene copy number gain lymphoma and double-hit lymphoma: results from a single institution retrospective clinical
Chemotherapy and Rituximab for NHL: Results from the Dose-Adjusted EPOCH Study | Research To Practice
Making an Informed Treatment Choice for Aggressive Non-Hodgkin Lymphoma: The R-CHOP Regimen versus EPOCH-R
